Atlas Trials

Cognition Therapeutics

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cognition Therapeutics

RecordFirmDate
A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease (NCT05531656)Cognition Therapeutics2023-06-28
Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD). (NCT05893537)Cognition Therapeutics2023-06-16
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies (NCT05225415)Cognition Therapeutics2022-05-19
Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers (NCT05248672)Cognition Therapeutics2022-02-15
Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects (NCT05225389)Cognition Therapeutics2021-12-31
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG (NCT04735536)Cognition Therapeutics2020-07-09
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease. (NCT03507790)Cognition Therapeutics2018-10-10
Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease (NCT03522129)Cognition Therapeutics2018-05-30
Effect of CT1812 Treatment on Brain Synaptic Density (NCT03493282)Cognition Therapeutics2018-03-28

Track Cognition Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.